Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 110 (3), 910-5

Effects of Somatostatin and Urotensin II on Tilapia Pituitary Prolactin Release and Interactions Between Somatostatin, Osmotic Pressure Ca++, and Adenosine 3',5'-monophosphate in Prolactin Release in Vitro

Effects of Somatostatin and Urotensin II on Tilapia Pituitary Prolactin Release and Interactions Between Somatostatin, Osmotic Pressure Ca++, and Adenosine 3',5'-monophosphate in Prolactin Release in Vitro

E G Grau et al. Endocrinology.

Abstract

Both somatostatin (SRIF) and urotensin II, a dodecapeptide from the teleost caudal neurosecretory system, inhibit PRL release from the organ-cultured rostral pars distalis of the tilapia, Sarotherodon mossambicus, in a dose-related manner. The inhibitory action of SRIF on PRL release was completely prevented by the presence of the calcium ionophore A23187. PRL release was also blocked when Ca++ was excluded from the incubation medium, even in the presence of the ionophore. Both dibutyryl cAMP (dbcAMP) and the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine, alone or in combination, stimulated PRL release during incubation in high osmotic pressure medium. The effect of dbcAMP appeared to be dose related. Together, dbcAMP and 3-isobutyl-1-methylxanthine were also effective in preventing the inhibition of PRL release by SRIF. These results are consistent with the notion that Ca++, and possibly cAMP, may be important mediators of PRL secretion, and it is likely that SRIF may inhibit PRL release by blocking a Ca++- or cAMP-mediated mechanism.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

Publication types

Feedback